Multiple Sclerosis
Brain health – time matters 2024: MS, NMOSD, MOGAD and related conditions
Since our first publication in 2015, care and treatment in neuroimmune conditions have hugely advanced. This new report delves into these advancements and addresses the ongoing needs of those living with these lifelong conditions. MS, NMOSD, and MOGAD are related, chronic, incurable diseases that can severely impact many aspects of life, especially when undiagnosed, misdiagnosed, or not treated early and effectively. Owing to this, expanding the scope of the report to include rare neuroimmune conditions may enable wide-reaching impact and improvements.
The new ‘Brain Health – Time Matters’ report emphasizes the importance of timely diagnosis and treatment initiation to enhance health outcomes, holistic person-centred care, and the consultation of robust, emerging evidence in this evolving research area.
The report, published by Oxford Health Policy Forum, is available for download on the dedicated MS Brain Health website www.msbrainhealth.org.
Our material may be used and reproduced without permission, however, anyone using the material is requested to properly cite and acknowledge the source. Please note that photographs or illustrations copyrighted by other organizations or individuals used by us may not be reproduced, for instance with translated copies or excerpts, or used without obtaining prior approval from the original holder of the photography/illustration copyright.
Brain Health: Time Matters in Multiple Sclerosis
Brain Health: Time Matters in Multiple Sclerosis presents consensus recommendations on diagnosis, therapeutic strategies and improving access to treatment in MS. Its core recommendation is that the goal of treating MS should be to preserve tissue in the central nervous system and maximize lifelong brain health by reducing disease activity. The report calls for major policy changes aimed at achieving the best possible outcomes for people with MS and those who care for them.
Brain Health: Time Matters in Multiple Sclerosis was developed by an international multidisciplinary group of experts under the chairmanship of Professor Gavin Giovannoni and has been endorsed by a number of professional associations and advocacy groups.
The report, published by Oxford Health Policy Forum, is available for download on the dedicated MS Brain Health website www.msbrainhealth.org, along with a number of other resources.
